Bolde400
Boldenone Propionate 45mg/ml
Boldenone Cypionate 155mg/ml
Boldenone Undeclynate 200 mg/ml
Anabolic:100
Androgenic:50
Side Effect:Moderate
Preparation: 400mg/ml
Structure: Ethyl Oleate Based Injectable
Packing: 10 ml clear glass vial / Transparant designer flipoff
Dosage: 400mg – 800mg / per week
Bolde400 Boldenone – Premium Multi-Ester Blend for Maximum Muscle Growth & Performance
Bolde400 Boldenone is a powerful blend combining three effective boldenone esters: Propionate (45mg/ml), Cypionate (155mg/ml), and Undecylenate (200mg/ml). This expertly formulated mix provides a balanced release profile delivering fast, medium, and long-lasting anabolic effects for consistent lean muscle growth, increased strength, and improved endurance.
Key Benefits:
-
💪 Fast and sustained lean muscle mass gains
-
⚡ Enhanced strength, stamina, and recovery
-
⏳ Balanced ester release for steady blood levels and fewer injections
-
🔥 Supports fat metabolism and muscle hardening
-
💧 Minimal water retention with quality muscle gains
Product Details:
-
Composition:
-
Boldenone Propionate 45mg/ml
-
Boldenone Cypionate 155mg/ml
-
Boldenone Undecylenate 200mg/ml
-
-
Total concentration: 400mg/ml
-
Administration: Injectable
-
Ideal for: Bulking, cutting, and performance enhancement cycles
Bolde400 is designed for athletes and bodybuilders looking for a comprehensive boldenone cycle that combines quick results with long-term anabolic support. It promotes nitrogen retention, red blood cell production, and collagen synthesis, aiding muscle growth and joint health.
Why Buy Our Bolde400?
-
✅ Pharmaceutical-grade purity and quality
-
🧪 Lab-tested for safety and potency
-
🚚 Fast, discreet worldwide shipping
-
💯 Trusted by professional athletes worldwide
Information about Delivery:
We ship orders via UPS, Fedex and usps. Preparation takes about 3 days and carrier needs 5 days to deliver. In total it takes 7-10 days.
All orders insured meaning that safe delivery is guaranteed | 5 or More Items free shipping worldwide !
Reviews
There are no reviews yet.